132 results match your criteria: "Hospital Klagenfurt[Affiliation]"
Calcif Tissue Int
July 2008
Department of Nuclear Medicine and Endocrinology, PET Center, State Hospital Klagenfurt, St. Veiterstr. 47, 9020, Klagenfurt, Austria.
Bone manifestations are frequent in Gaucher disease (GD), the most prevalent lysosomal storage disorder. Currently, therapy with enzyme replacement (ERT) or substrate reduction (SRT) is available. We investigated changes of laboratory parameters associated with bone metabolism in GD patients switching from ERT to SRT.
View Article and Find Full Text PDFTher Clin Risk Manag
March 2006
Pain Clinic, General Hospital Klagenfurt Klagenfurt, Austria.
By virtue of their efficacy, opioid analgesics have long been used for the treatment of both acute and chronic pain. Concerns regarding their safety and tolerability have frequently prevented this class of drugs achieving their full therapeutic potential, and their reported association with drug abuse and dependence has led to a reduced acceptance by many patients. Indeed, there is a variety of opioid-like side effects which are common to all members of the class, but some opioids have a more favourable safety profile than others.
View Article and Find Full Text PDFEur J Nucl Med Mol Imaging
May 2008
Department of Nuclear Medicine and Endocrinology, PET/CT Center, Klagenfurt, State Hospital Klagenfurt, St.Veiterstrasse 47, A-9020 Klagenfurt, Austria.
Purpose: Patients with persistent elevated PSA and repeated negative prostate biopsy, that means having the prostate biopsied at multiple times, were investigated with 18F-choline PET/CT to delineate prostate cancer and guide renewed prostate biopsy.
Methods: Twenty patients with elevated PSA and negative prostate biopsies underwent 18F-choline PET/CT. We performed an early examination of the pelvic region 3-5 min after application.
Int J Clin Pract
January 2008
Pain Clinic, General Hospital Klagenfurt, Klagenfurt, Austria.
Aims: Opioids produce analgesia via different pain pathways. The aim of these case studies was to address the issue of opioid rotation or switching, raising the important issue of conversion ratios between different compounds and routes of administration.
Results: We present two cases of neuropathic pain and two cases of nociceptive pain with a significant neuropathic component, which were successfully treated with transdermal buprenorphine after the failure of other opioids.
Eur J Pediatr Surg
December 2007
Department of Paediatric Surgery, General Hospital Klagenfurt, St. Veiter Strasse 47, Klagenfurt, Austria.
We report on the application of OK-432 (picibanil) in a patient with prolonged wound healing impairment. A 13-year-old girl had suffered a polytrauma with a displaced fracture of the sacrum which required neurosurgical decompression of the sacral plexus. Postoperatively, a seroma with recurrent fistulation was seen.
View Article and Find Full Text PDFClin Ther
August 2007
Interdisciplinary Pain Clinic, General Hospital Klagenfurt, Klagenfurt, Austria.
Background: In 2001, a transdermal matrix patch formulation of buprenorphine was approved for the treatment of moderate to severe cancer pain and severe pain that is unresponsive to nonopioid analgesics. The primary recommendation contained in the prescribing information was that transdermal patches be worn for a 3-day period before application of a new patch.
Objective: This study was conducted to evaluate the potential for extending the time the buprenorphine patch is worn from 3 to 4 days.
Bioelectromagnetics
July 2007
Department of Anaesthesiology and Critical Care Medicine, Trauma Hospital Klagenfurt, Waidmannsdorferstrasse 35, Klagenfurt, Austria.
The extent of electromagnetic interference (EMI) from 16.7-Hz alternate current power lines in the human surface electrocardiogram (ECG) was evaluated. Results showed a direct linear correlation between mean EMI and magnetic induction of 5.
View Article and Find Full Text PDFClin Ther
June 2006
Pain Clinic, General Hospital Klagenfurt, Klagenfurt, Austria, and Pain Clinic, University of Erlangen-Nürnberg, Germany.
Background: Transdermal buprenorphine is available in Europe for the treatment of moderate to severe chronic pain. It has been evaluated at doses of 35, 52.5, and 70 microg/h for the management of moderate to severe chronic cancer and noncancer pain in 3 randomized, double-blind, placebo-controlled trials, each of limited duration (approximately 14 days each).
View Article and Find Full Text PDFAnesth Analg
March 2005
*Pain Clinic, General Hospital Klagenfurt, Klagenfurt, Austria; and †University of Erlangen Pain Clinic, Erlangen, Germany.
The use of opioids for treating neuropathic pain is controversial, and some studies have indicated that neuropathic pain may be relatively insensitive to typical mu-opioid analgesics such as morphine. However, it is becoming clear that different opioids produce analgesia by affecting different pain pathways. We present two cases of neuropathic pain and two cases of nociceptive pain with a significant neuropathic component that were treated with transdermal buprenorphine.
View Article and Find Full Text PDFIntensive Care Med
March 2005
Department of Anaesthesia and Intensive Care Medicine, County Hospital Klagenfurt, Austria.
Purpose: Patients in the ICU after long-term administration of an opioid/hypnotic often develop delirium. To assess the nature of this phenomenon, patients in a surgical ICU following ventilatory support and sedation with an opioid/hypnotic/sedative were studied.
Methodology: Following sufentanil/midazolam (group 1; n =14) or sufentanil/propofol (group 2; n =15) sedation, patients were evaluated for changes in mean arterial blood pressure and heart rate, the activity of the central nervous system (sensory evoked potentials, spectral edge frequency of EEG), and the endogenous opioids plasma concentrations (beta-endorphin, met-enkephalin).
J Thorac Cardiovasc Surg
September 2003
Department of Cardiothoracic Surgery, General Hospital Klagenfurt, St Veiter Strasse 47, A-9020 Klagenfurt, Austria/Europe.
Acta Med Austriaca
August 2003
Department of Nuclear Medicine and Endocrinology, PET Centre, Hospital Klagenfurt, Austria.
Background: The aim of this retrospective study was to evaluate the accuracy of fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG-PET) images, which were interpreted under daily routine conditions, in patients with Hodgkin's disease (HD) or non-Hodgkin lymphoma (NHL) for restaging after chemotherapy and/or radiotherapy. For this purpose, 18F-FDG-PET results were compared with morphological imaging methods and the patients' clinical background.
Methods: 121 PET images of 93 lymphoma patients (44 HD, 49 NHL) were investigated after chemotherapy/radiotherapy.
Invest Radiol
May 2003
Department of Nuclear Medicine and Endocrinology, PET Center, State Hospital Klagenfurt, Austria.
Aim: To evaluate the role of F-18-fluorodeoxyglucose positron-emission tomography (F-18 FDG PET) in the follow-up of breast carcinoma in case of clinical suspicion of local recurrence or distant metastases and/or tumor marker increase in correlation to conventional imaging.
Material And Methods: Retrospective analysis of the results of F-18 FDG PET (ECAT ART(R), Siemens CTI MS) of 62 patients (age 58.5 +/- 12.
Urology
January 2003
Department of Urology, General Hospital Klagenfurt, Klagenfurt, Austria, Austria.
Objectives: To report the indications, technique, and results in patients with primary hyperaldosteronism due to aldosterone-producing adrenal adenoma treated by laparoscopic partial adrenalectomy. Laparoscopy has become the technique of choice in adrenal surgery, but adrenalectomy is the standard procedure. Only a few studies have reported on partial adrenalectomy, and the indications and technique have not yet been clearly defined.
View Article and Find Full Text PDFThyroid
September 2002
Department of Nuclear Medicine and Special Endocrinology, PET Centre, State Hospital Klagenfurt, Austria.
The objective of this epidemiologic study was to determine the volume of the thyroid gland as well as urinary iodine excretion in dependence on age and gender in a population from an area of low natural iodine supply now receiving iodine prophylaxis. In 430 persons from three communities in the province of Carinthia, Austria, we determined thyroid volume via sonography as well as urinary iodide excretion. As in numerous other European countries, natural iodine supply is insufficient in Austria.
View Article and Find Full Text PDFJ Urol
November 2002
Department of Urology, General Hospital Klagenfurt, Austria.
Nuklearmedizin
October 2001
Department of Nuclear Medicine and Endocrinology, State Hospital Klagenfurt, Austria.
Aim: The goal of this study was to assess the accuracy and limitations of ultrasound guided fine-needle aspiration biopsy (ug-FNAB) of solitary thyroid nodules.
Methods: The ug-FNAB results of 538 patients with solitary thyroid nodules, who afterwards underwent thyroid surgery, were compared retrospectively with the histology. Patients with multinodular goiter were excluded from the study.
Urology
November 2001
Department of Urology, General Hospital Klagenfurt, Klagenfurt, Austria.
Objectives: To report our experience with laparoscopic nephron-sparing surgery. Because of the widespread use of ultrasonography and computed tomography, laparoscopy is becoming more and more important in the surgical management of solid renal masses. Although laparoscopic radical nephrectomy has gained wide acceptance, laparoscopic nephron-sparing surgery for renal tumors is still rarely done.
View Article and Find Full Text PDFClin Nucl Med
October 2001
Department of Nuclear Medicine and Endocrinology, PET Centre, General Hospital Klagenfurt, Klagenfurt, Austria.
Ann Thorac Surg
August 2001
Department of Cardiothoracic Surgery, General Hospital Klagenfurt, Austria.
We report a case of near drowning of a 3-year-old girl, who was admitted to our emergency room with a core temperature of 18.4 degrees C. After rewarming on cardiopulmonary bypass and restitution of her circulation, respiratory failure resistant to conventional respiratory therapy prohibited weaning from cardiopulmonary bypass.
View Article and Find Full Text PDFEur J Nucl Med
July 2001
Department of Nuclear Medicine and special Endocrinology, PET Centre, General Hospital Klagenfurt, Austria.
The aim of this study was to evaluate the usefulness of 18F-FDG PET in the diagnosis and staging of primary and recurrent malignant head and neck tumours in comparison with conventional imaging methods [including ultrasonography, radiography, computed tomography (CT) and magnetic resonance imaging (MRI)], physical examination, panendoscopy and biopsies in clinical routine. A total of 54 patients (13 female, 41 male, age 61.3+/-12 years) were investigated retrospectively.
View Article and Find Full Text PDFEur J Nucl Med
July 2001
Department of Nuclear Medicine and special Endocrinology, PET Centre, General Hospital Klagenfurt, St. Veiterstrasse 47, 9020 Klagenfurt, Austria, Austria,
The aim of this study was to evaluate the usefulness of (18)F-FDG PET in the diagnosis and staging of primary and recurrent malignant head and neck tumours in comparison with conventional imaging methods [including ultrasonography, radiography, computed tomography (CT) and magnetic resonance imaging (MRI)], physical examination, panendoscopy and biopsies in clinical routine. A total of 54 patients (13 female, 41 male, age 61.3±12 years) were investigated retrospectively.
View Article and Find Full Text PDFThyroid
March 2001
Department of Nuclear Medicine and Special Endocrinology, State Hospital Klagenfurt, Austria.
The aim of this study was to examine different influences on bone degradation (estrogen status, thyroid function, parathyroid function, bone metastases) with special interest focusing on the significance of suppressive levothyroxine therapy (LT4) on bone degradation in patients with differentiated thyroid carcinoma (DTC). Two markers of bone degradation (ELItest NTx = U-NTx; Serum CrossLaps = S-CTx) were used (1) to quantify the influence of different metabolic influences on bone degradation and (2) to compare these two markers with each other. One hundred forty samples of 98 female patients ages 23-86 years were analyzed.
View Article and Find Full Text PDFAnn Thorac Surg
November 2000
Department of Cardiothoracic Surgery, Institute for Laboratory Medicine, General Hospital Klagenfurt, Austria.
Background: Cardiac operations using extracorporeal circulation bear a risk of cerebral complications. The aim of our study was to investigate if off-pump operations without heart-lung machines can reduce cerebral injury.
Methods: S100, a protein specific for cerebral tissue, was used as a marker for cerebral impairment in 108 randomized patients undergoing coronary bypass operation: 67 patients (group A) were operated on with extracorporeal circulation and cardioplegic cardiac arrest, and 41 patients (group B) underwent off-pump beating heart revascularization.
Invest Radiol
August 2000
Department of Nuclear Medicine and Special Endocrinology, State Hospital Klagenfurt, Austria.
Rationale And Objectives: Technetium-99m-((99m)Tc-) tetrofosmin, a cationic, lipophilic complex like (99m)Tc-sestamibi, has proved to be a potential tracer for parathyroid scintigraphy despite some differences in washout behavior from the thyroid gland. Previous results comparing a double-phase technique with single-proton emission computed tomography (SPECT) or with subtraction techniques demonstrated a high detection rate, especially when SPECT and subtraction techniques were used, whereas the double-phase protocol revealed only moderate results. In this study, a direct comparison was made between (99m)Tc-tetrofosmin/pertechnetate subtraction and SPECT to elucidate the optimal protocol for tetrofosmin parathyroid imaging.
View Article and Find Full Text PDF